SEC Form 4 · accession 0001209191-15-001011
AUXILIUM PHARMACEUTICALS INC · AUXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rolf A Classon
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001182129
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2014 | A | 260 | $34.385 | A | 10,260 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person received these shares of common stock pursuant to the Auxilium Pharmaceuticals, Inc. 2004 Equity Compensation Plan in lieu of payment to the reporting person of $8,940.10 of his director's fees for the quarter ended December 31, 2014.